Xylem said revenue for 2023 was $7,364 million, up $1,842 million, or 33.4%, from $5,522 million in 2022. The company said the increase on a constant currency basis consisted of $1,177 million of revenue from acquisitions and $690 million of organic revenue growth.

1. 01

   Xylem said revenue for 2023 was $7,364 million, up $1,842 million, or 33.4%, from $5,522 million in 2022. The company said the increase on a constant currency basis consisted of $1,177 million of revenue from acquisitions and $690 million of organic revenue growth.

2. 02

   The company said operating income for 2023 was $652 million (an operating margin of 8.9%), up from $622 million (11.3%) a year earlier. It said adjusted operating income, which excludes special charges, acquired intangible asset amortization, and restructuring and realignment costs, was $1,072 million (14.6%), compared with $744 million (13.5%) a year earlier.

3. 03

   Xylem said it completed its acquisition of Evoqua on May 24, 2023. The all-stock transaction reflected an implied enterprise value of about $7.5 billion. The company said all of the Integrated Solutions and Services segment's revenue for 2023, $815 million, came from the Evoqua acquisition.

4. 04

   Xylem said net cash provided by operating activities for 2023 was $837 million, up $241 million from $596 million in 2022. The company said it had about $2 billion of available liquidity, consisting of $1 billion in cash and $1 billion of available credit facilities.

Key figures

Fiscal year ended December 31, 2023

Revenue

$7.4B

Operating income

$652M

Net income

$609M

EPS

$2.79

Gross profit

$2.7B

Operating cash flow

$837M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.